1. Home
  2. Labeler Index
  3. Alexion Pharmaceuticals Inc.
  4. 25682-025
  5. NDC Package Code: 25682-025-01 Ultomiris

NDC Package 25682-025-01 Ultomiris

Ravulizumab Solution, Concentrate Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
25682-025-01
Package Description:
1 VIAL, GLASS in 1 CARTON / 3 mL in 1 VIAL, GLASS
Product Code:
25682-025
Proprietary Name:
Ultomiris
Non-Proprietary Name:
Ravulizumab
Substance Name:
Ravulizumab
Usage Information:
Ravulizumab-cwvz is used to treat a certain blood disorder (paroxysmal nocturnal hemoglobinuria). This disorder causes your body's immune system to destroy red blood cells, which results in anemia. It works by helping block your body's destruction of red blood cells. This effect helps lessen symptoms of anemia (such as tiredness, shortness of breath), and may reduce the need for blood transfusions. This medication may also be used to treat a certain immune system disorder (atypical Hemolytic Uremic Syndrome). It helps to prevent blood clots caused by this disorder. Ravulizumab-cwvz belongs to a class of medications known as monoclonal antibodies.
11-Digit NDC Billing Format:
25682002501
NDC to RxNorm Crosswalk:
  • RxCUI: 2107320 - ravulizumab-cwvz 300 MG in 30 ML Injection
  • RxCUI: 2107320 - 30 ML ravulizumab-cwvz 10 MG/ML Injection
  • RxCUI: 2107320 - ravulizumab-cwvz 300 MG per 30 ML Injection
  • RxCUI: 2107325 - ULTOMIRIS 300 MG in 30 ML Injection
  • RxCUI: 2107325 - 30 ML ravulizumab-cwvz 10 MG/ML Injection [Ultomiris]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Alexion Pharmaceuticals Inc.
    Dosage Form:
    Solution, Concentrate - A liquid preparation (i.e., a substance that flows readily in its natural state) that contains a drug dissolved in a suitable solvent or mixture of mutually miscible solvents; the drug has been strengthened by the evaporation of its nonactive parts.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • RAVULIZUMAB 300 mg/3mL
    • Pharmacologic Class(es):
  • Complement Inhibitor - [EPC] (Established Pharmacologic Class)
  • Complement Inhibitors - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    BLA761108
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    10-09-2020
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 25682-025-01 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    25682002501J1303Inj., ravulizumab-cwvz 10 mg10 MG313030

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 25682-025-01?

    The NDC Packaged Code 25682-025-01 is assigned to a package of 1 vial, glass in 1 carton / 3 ml in 1 vial, glass of Ultomiris, a human prescription drug labeled by Alexion Pharmaceuticals Inc.. The product's dosage form is solution, concentrate and is administered via intravenous form.

    Is NDC 25682-025 included in the NDC Directory?

    Yes, Ultomiris with product code 25682-025 is active and included in the NDC Directory. The product was first marketed by Alexion Pharmaceuticals Inc. on October 09, 2020 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 25682-025-01?

    The 11-digit format is 25682002501. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-225682-025-015-4-225682-0025-01